Danazol and oral anticoagulants

Area of Science:

• Pharmacology
• Hematology
• Gynecology

Background:

• Warfarin is a common anticoagulant used to prevent thrombosis.
• Danazol is an anabolic steroid prescribed for conditions like menorrhagia.
• Drug interactions between anticoagulants and anabolic steroids require careful consideration.

Observation:

• A case report details a young woman on warfarin experiencing overt bleeding.
• The patient was concurrently administered danazol for managing menorrhagia.
• This specific drug interaction is infrequently recognized in clinical practice.

Findings:

• The co-administration of warfarin and danazol led to an adverse bleeding event.
• The interaction suggests a significant potentiation of warfarin's anticoagulant effect by danazol.
• Thrombotest monitoring is crucial for dose adjustment.

Implications:

• Clinicians should be aware of the potential for severe bleeding when prescribing danazol to patients on warfarin.
• Initiating warfarin therapy with a reduced dose (halved) is recommended when danazol is introduced.
• Ongoing thrombotest monitoring is essential to tailor the anticoagulant dose effectively and ensure patient safety.